AS

Arpita Singh

Active Director Director DIN 07785429
DIN 07785429 First appointment Nov 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Arpita Singh

Data last updated:

Arpita Singh is a Director at Docturnal Private Limited (since 2019). The company operates in Healthcare. Docturnal Private Limited reported revenue of ₹19.1 Lakh (FY 2023).

DIN 07785429
Primary Designation Director
Industry Healthcare
First Appointment 05 Nov 2019
Oldest Company Age 10 yrs
Largest company Docturnal Private Limited · ₹19.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Docturnal Private Limited U85190TG2016PTC109301
Director05 Nov 20192016₹19.1 Lakh (FY 2023)Active

Board colleagues of Arpita Singh

Directorship timeline

Open interactive timeline →
Docturnal Private Limited
Premium access

Shareholding and investment profile for Arpita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpita Singh

Arpita Singh currently holds 1 directorship: Docturnal Private Limited (Director, since 05 Nov 2019, revenue ₹19.1 Lakh (FY 2023)).

Arpita Singh was first appointed on 05 Nov 2019 as Director at Docturnal Private Limited.

The current boards of Arpita Singh's companies include Balakrishna Bagadi (Docturnal Private Limited), Rahul Pathri (Docturnal Private Limited), Vaishnvi Gutha Reddy (Docturnal Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available